Liver Disease Treatments: The Global Market

BCC Research
January 1, 2012
214 Pages - SKU: WA6802589
Countries covered: Global

In 2009, the global market for drugs used to treat liver disease was worth approximately $12.4 billion. Sales in 2010 decreased and the market did not see much progress, causing overall global sales to remain stagnant at $12.4 billion. Estimated sales in 2011 a projected $12 billion (excluding protease inhibitors). The market is expected to rise at a CAGR of 3.3% and reach nearly $14.2 billion by 2016.

The U.S. region constituted approximately 36% of the total market for drugs used to treat liver disease in 2010 and was valued at $4.5 billion. In 2011, the market continued to decrease and will hit nearly $4.2 billion. BCC expects this market to increase in the future rising at a CAGR of 3% to reach nearly $4.9 billion by 2016.

The European market constituted approximately 31% of the total market and was $3.8 billion in 2010. This market is expected to see a decrease in 2011 totaling nearly $3.6 billion. This market is forecast to grow at a CAGR of 1% and should be worth $3.7 billion by 2016.


Additional Information

INTRODUCTION

STUDY OBJECTIVES

BCC Research’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for liver disease drugs, including the market for end users. The key objective is to present a comprehensive analysis of the current liver disease drug market and its future direction by utilizing new methods for preventing globally widespread disease.

This report explores present and future strategies within the liver disease drug market, including market sizes, market leaders, market overview, and various other market factors, as well as the market for end users. The current state of the market, its setbacks, its innovations, and its future needs are also discussed.

A detailed analysis of the liver disease drug market and the industry structure has been conducted. This includes the different categories of liver disease drugs and the various types of liver disease broken down by market share belonging to leading manufacturers and/or suppliers. Revenues for each drug category and disease type are broken down by region. Sales figures are estimated for the 5-year period from 2011 through 2016.

The strategies and the prospects of the current market are also discussed. Companies that manufacture and sell new and innovative liver disease-related drugs are also profiled.

REASONS FOR DOING THIS STUDY

This study was conducted to provide detailed information regarding different liver disease drugs in response to an increasing need for new and innovative drug treatments. This industry is experiencing growth, as new product lines have been launched (e.g., Protease inhibitors for the treatment of hepatitis). The study looks at most of the different drug types and different liver diseases. It cites the research and development for almost all new drugs and applications. The changes in market behavior demonstrate the need to focus on this segment. Additionally, the study discusses the treatment options provided by these drugs to end users. Acquisitions, mergers, and alliances by companies and global organizations are also discussed.

INTENDED AUDIENCE

This study examines the areas of growth in the liver disease drug market from the point of view of both manufacturers and users. This study will be of interest largely to the pharmaceutical and biopharmaceutical industries, clinics, hospitals, and research institutes.

SCOPE OF THE STUDY

The scope of this study encompasses liver disease drug markets by various types. BCC Research analyzes each market by category with its applications in different regions of the world. It also analyzes the market leaders, regulatory environment, technology, market projections, and market share. Application issues include the latest trends and developments in each liver disease drug category.
METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study. BCC conducted a comprehensive literature search, which included technical newsletters and journals, as well as many other sources. Data were collected through interviews and correspondence with various trade experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

More Vaccines reports by BCC Research

DNA Vaccines: Technologies and Global Markets by BCC Research
DNA Vaccines: Technologies and Global Markets The global market for DNA vaccines was valued at $243.7 million in 2013 and is expected to increase to ...
The Global Influenza Market by BCC Research
The Global Influenza Market The global influenza market will grow from nearly $3.8 billion in 2012 to $4 billion in 2013. Market revenue is forecast ...
Global Markets and Manufacturing Technologies for Protein Drugs - Focus on Blood Factors, Vaccines and Peptide Antibiotics by BCC Research
Global Markets and Manufacturing Technologies for Protein Drugs - Focus on Blood Factors, Vaccines and Peptide Antibiotics This report provides: An overview of the markets ...
Global Markets for Vaccine Technologies by BCC Research
Global Markets for Vaccine Technologies provides: An overview of the global market for human and animal (veterinary) vaccines and related vaccine technologies. Analyses ...
See all reports like this >>

More Global Vaccines reports

Global Pneumococcal Vaccines Market : 2014-2018 by TechNavio - Infiniti Research Ltd.
Global Pneumococcal Vaccines Market 2014-2018About Pneumococcal Disease and Its PreventionPneumococcus (Streptococcus pneumonia), a pathogenic bacterium, is the leading cause of serious illness across the globe. ...
Global Animal Vaccines Market 2014-2018 by TechNavio - Infiniti Research Ltd.
About Animal VaccinesAnimal vaccines are biological preparations used to improve the immunity of animals. Animal vaccines are generally prepared from weakened or dead microbes that ...
Global Hepatitis B Vaccines Market : 2014-2018 by TechNavio - Infiniti Research Ltd.
Press ReleaseTechNavio Announces the Publication of its Research Report - Global Hepatitis B Vaccines Market 2014-2018TechNavio recognizes the following companies as the key players in ...
Global Meningococcal Vaccines Market : 2014-2018 by TechNavio - Infiniti Research Ltd.
Press ReleaseTechNavio Announces the Publication of its Research Report - Global Meningococcal Vaccines 2014-2018 TechNavio recognizes the following companies as the key players in the ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 6,650  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!